Projects

Presentation , tReatment, challenges and Opportunities for optimal Treatments in the Elderly with select Chronic condiTions (PROTECT)

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2024 - 2025

Project Lead

Dr. Geetha Ann Francis

Authors

Dr. Geetha Ann Francis

Project Status

completed

Project Type

No external funding (Intramural